Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DG07WN
|
|||
| Drug Name |
RGX-314
|
|||
| Drug Type |
Gene therapy
|
|||
| Indication | Wet age-related macular degeneration [ICD-11: 9B78.3Z; ICD-10: H35.31] | Phase 2 | [1] | |
| Company |
REGENXBIO
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04832724) RGX-314 Gene Therapy Pharmacodynamic Study for Neovascular Age-related Macular Degeneration (nAMD). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.